BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20575763)

  • 1. Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure.
    Núñez J; Chilet M; Sanchis J; Bodí V; Núñez E; Miñana G; Tormo N; Clari MA; Pellicer M; Chorro FJ; Llàcer A; Navarro D
    Clin Sci (Lond); 2010 Aug; 119(10):443-52. PubMed ID: 20575763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Reddy V; Meier-Kriesche HU; Greene S; Schold JD; Wingard JR
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):698-705. PubMed ID: 16125640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
    Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.
    Chilet M; Aguilar G; Benet I; Belda J; Tormo N; Carbonell JA; Clari MA; Costa E; Navarro D
    J Med Virol; 2010 Aug; 82(8):1384-91. PubMed ID: 20572085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of pro-inflammatory cytokine mobilization predicts poor prognosis in patients with acute heart failure.
    Vistnes M; Høiseth AD; Røsjø H; Nygård S; Pettersen E; Søyseth V; Hurlen P; Christensen G; Omland T
    Cytokine; 2013 Mar; 61(3):962-9. PubMed ID: 23415671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.
    Lévêque N; Brixi-Benmansour H; Reig T; Renois F; Talmud D; Brodard V; Coste JF; De Champs C; Andréoletti L; Diebold MD
    J Med Virol; 2010 Oct; 82(10):1694-700. PubMed ID: 20827767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
    J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?
    Weatherley BD; Milo-Cotter O; Felker GM; Uriel N; Kaluski E; Vered Z; O'Connor CM; Adams KF; Cotter G
    Fundam Clin Pharmacol; 2009 Oct; 23(5):633-9. PubMed ID: 19656213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.
    D'Ovidio V; Vernia P; Gentile G; Capobianchi A; Marcheggiano A; Viscido A; Martino P; Caprilli R
    J Clin Virol; 2008 Oct; 43(2):180-3. PubMed ID: 18614396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
    Guech-Ongey M; Brenner H; Twardella D; Hahmann H; Rothenbacher D
    Int J Cardiol; 2006 Jul; 111(1):98-103. PubMed ID: 16229909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients].
    Niubò J; Pérez JL; Manito N; García A; Roca J; Martín R
    Med Clin (Barc); 1999 Feb; 112(4):121-4. PubMed ID: 10074629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient worsening of renal function during hospitalization for acute heart failure alters outcome.
    Logeart D; Tabet JY; Hittinger L; Thabut G; Jourdain P; Maison P; Tartiere JM; Solal AC
    Int J Cardiol; 2008 Jul; 127(2):228-32. PubMed ID: 17651843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
    Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
    Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.